Impact of Severe Postoperative Multi‐Organ Dysfunction on Long‐Term Outcomes After Modified Morrow Surgery
Clinical Cardiology · 2026
DOI: 10.1002/clc.70434 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Clinical Cardiology, 2026. Verfasst von Tong Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Cardiac Surgery, Beijing An Zhen Hospital Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Cardiac Surgical Procedures, Cardiomyopathy, Hypertrophic, Multiple Organ Failure, Postoperative Complications. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Beijing Nova Program, Beijing Natural Science Foundation, Natural Science Foundation of Beijing Municipality.
Abstract (Originalsprache)
Background
The modified Morrow surgery is the gold standard surgical treatment for hypertrophic obstructive cardiomyopathy (HOCM). While effective, it carries a risk of postoperative severe multi‐organ dysfunction and its impact on long‐term cardiovascular outcomes remains poorly understood and controversial.
Methods
This observational cohort study included 380 HOCM patients undergoing the modified Morrow surgery between July 2015 and March 2025. Severe multi‐organ dysfunction was defined as a maximum Sequential Organ Failure Assessment (SOFA) score ≥ 11. The primary endpoint was the long‐term incidence of major adverse cardiac and cerebrovascular events (MACCEs). Secondary endpoints included heart failure hospitalization (HFH), postoperative atrial fibrillation (AF) ablation, and cardiovascular mortality.
Results
Compared to patients without severe multi‐organ dysfunction (SOFA Maximum < 11, n = 234), those with SOFA Maximum ≥ 11 ( n = 146) had significantly higher rates of MACCEs (53.4% vs. 17.5%, p < 0.001), cardiovascular mortality (11.6% vs. 0.9%, p < 0.001), HFH (21.9% vs. 8.5%, p < 0.001), and postoperative AF ablation (17.8% vs. 3.8%, p < 0.001). Multivariable Cox proportional hazards regression demonstrated that severe multi‐organ dysfunction was independently associated with cardiovascular mortality (HR = 4.157, p = 0.047), MACCEs (HR = 2.296, p < 0.001), HFH (HR = 1.834, p = 0.042), and postoperative AF ablation (HR = 3.987, p < 0.001). Other independent predictors included family history of hypertrophic cardiomyopathy, left ventricular end‐systolic dimension, postoperative left ventricular outflow tract velocity, and postoperative surgical intensive care unit ventilation time.
Conclusions
Postoperative severe multi‐organ dysfunction is independently associated with an increased risk of adverse long‐term outcomes after modified Morrow surgery. Incorporating the SOFA score into postoperative risk stratification may help identify high‐risk patients warranting intensified long‐term management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Cardiac Surgery, Beijing An Zhen Hospital Capital Medical University, Beijing, China.
ORCID-Profile: Ran Dong, Jiayang Wang
Förderung
- Beijing Nova Program
- Beijing Natural Science Foundation
- Natural Science Foundation of Beijing Municipality
Zitieren
APA
Wang, T., Ta, Zhang, K., Dong, R., Xiao, Y., & Wang, J. (2026). Impact of Severe Postoperative Multi‐Organ Dysfunction on Long‐Term Outcomes After Modified Morrow Surgery. Clinical Cardiology. https://doi.org/10.1002/clc.70434
Vancouver
Wang T, Ta, Zhang K, Dong R, Xiao Y, Wang J. Impact of Severe Postoperative Multi‐Organ Dysfunction on Long‐Term Outcomes After Modified Morrow Surgery. Clinical Cardiology. 2026. doi:10.1002/clc.70434
BibTeX
@article{Wang2026,
author = {Wang, Tong and Ta, La and Zhang, Kui and Dong, Ran and Xiao, Yu and Wang, Jiayang},
title = {Impact of Severe Postoperative Multi‐Organ Dysfunction on Long‐Term Outcomes After Modified Morrow Surgery},
journal = {Clinical Cardiology},
year = {2026},
doi = {10.1002/clc.70434}
}
EUVIMED